{"title":"人工智能在糖尿病视网膜病变中的应用","authors":"Sashwanthi Mohan, Ritika Gaur, R. Raman","doi":"10.25259/ihopejo_20_2022","DOIUrl":null,"url":null,"abstract":"Diabetic retinopathy (DR), a microvascular complication of diabetes, is a leading cause of blindness in India. Regular and timely screening for DR is recommended for the early diagnosis and appropriate treatment. However, mass screening for DR poses a significant challenge. Artificial intelligence (AI) is an important tool which has been used for diagnosing and grading diabetic retinopathy and aids in mass DR screening thus helping in faster and earlier screening of DR. This article aims to describe how AI is used in DR, software that are available for screening and the limitations and challenges in implementation of AI in health-care settings.","PeriodicalId":176313,"journal":{"name":"IHOPE Journal of Ophthalmology","volume":"148 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Using artificial intelligence in diabetic retinopathy\",\"authors\":\"Sashwanthi Mohan, Ritika Gaur, R. Raman\",\"doi\":\"10.25259/ihopejo_20_2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diabetic retinopathy (DR), a microvascular complication of diabetes, is a leading cause of blindness in India. Regular and timely screening for DR is recommended for the early diagnosis and appropriate treatment. However, mass screening for DR poses a significant challenge. Artificial intelligence (AI) is an important tool which has been used for diagnosing and grading diabetic retinopathy and aids in mass DR screening thus helping in faster and earlier screening of DR. This article aims to describe how AI is used in DR, software that are available for screening and the limitations and challenges in implementation of AI in health-care settings.\",\"PeriodicalId\":176313,\"journal\":{\"name\":\"IHOPE Journal of Ophthalmology\",\"volume\":\"148 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IHOPE Journal of Ophthalmology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/ihopejo_20_2022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IHOPE Journal of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ihopejo_20_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Using artificial intelligence in diabetic retinopathy
Diabetic retinopathy (DR), a microvascular complication of diabetes, is a leading cause of blindness in India. Regular and timely screening for DR is recommended for the early diagnosis and appropriate treatment. However, mass screening for DR poses a significant challenge. Artificial intelligence (AI) is an important tool which has been used for diagnosing and grading diabetic retinopathy and aids in mass DR screening thus helping in faster and earlier screening of DR. This article aims to describe how AI is used in DR, software that are available for screening and the limitations and challenges in implementation of AI in health-care settings.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
